Afuco™ Anti-Human Collagen ADCC Therapeutic Antibody (MT293), ADCC Enhanced
Anti-Collagen ADCC Enhanced Antibody (MT293) is an ADCC enhanced antibody produced by our Afuco™ platform. MT293 also known as TRC093, is being developed in a phase 1 clinical trial for the treatment of patients with cancer.
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-172CL |
| Pricing | Inquiry |
| Host | Humanized |
| Target | Collagen |
| Species Reactivity | Human |
| Type | ADCC enhanced antibody |
| Storage | 4°C or -20°C, avoid repeated freezing and thawing. |